Biologics

FDA Approves Dupixent for Allergic Fungal Rhinosinusitis

Physician’s Briefing

FDA Approves Dupixent for Allergic Fungal Rhinosinusitis

26 Feb 2026

2 min read

One Year of Abatacept Delays Progression to RA for Up to Four Years in At-Risk Population

Physician’s Briefing

One Year of Abatacept Delays Progression to RA for Up to Four Years in At-Risk Population

23 Jan 2026

2 min read

Recommendations Developed for Optimizing Biologics in Adults With Severe Asthma

Physician’s Briefing

Recommendations Developed for Optimizing Biologics in Adults With Severe Asthma

22 Jan 2026

2 min read

Read More

Clinical Briefing Report

clinicalbriefingreport.com